Description

Product details

EVERENOLIMUS 0.5 is a prescription medication containing Everolimus 0.5 mg tablets, a potent mTOR (mammalian target of rapamycin) inhibitor used in advanced medical treatments. This medicine works by regulating cell growth, division, and immune system activity, making it effective in both oncology and transplant care. Everolimus has become a crucial therapeutic option for patients requiring targeted cancer therapy or immunosuppression after organ transplantation. Its dual functionality—controlling abnormal cell proliferation and preventing organ rejection—makes it a preferred choice among healthcare providers. In India, EVERENOLIMUS 0.5 is increasingly prescribed for specific cancers, post-transplant care, and rare disorders like tuberous sclerosis complex. Its oral tablet form allows convenient administration while maintaining effective systemic action. Uses of EVERENOLIMUS 0.5 EVERENOLIMUS 0.5 is indicated for a range of serious medical conditions: 1. Organ Transplantation Helps prevent rejection of kidney and liver transplants Maintains graft survival by suppressing the immune response 2. Cancer Treatment Hormone receptor-positive, HER2-negative advanced breast cancer Advanced kidney cancer (renal cell carcinoma) Neuroendocrine tumors (pancreas, lungs, gastrointestinal tract) 3. Tuberous Sclerosis Complex (TSC) Manages non-cancerous tumors such as subependymal giant cell astrocytoma (SEGA) Reduces tumor growth in vital organs 4. Other Rare Conditions Certain types of cardiac or renal vascular growth disorders, under specialist supervision Benefits of EVERENOLIMUS 0.5 1. Dual Therapeutic Action Offers immunosuppressive benefits for transplant patients Provides targeted anti-cancer activity to control abnormal cell growth 2. Improved Transplant Outcomes Reduces the risk of graft rejection Ensures long-term functionality of transplanted organs 3. Targeted Cancer Therapy Focuses on specific cellular pathways Minimizes damage to healthy cells compared to conventional chemotherapy 4. Slows Disease Progression Effective in advanced cancers and benign tumors Controls disease symptoms and improves patient quality of life 5. Convenient Oral Formulation Easy to take as a tablet without injections Enables consistent and controlled drug delivery 6. Enhances Long-Term Management Regular use supports chronic disease control Reduces hospitalization and complication rates Dosage of EVERENOLIMUS 0.5 The exact dosage depends on the patient’s condition, weight, and response to therapy. It must be determined by a healthcare professional. General Guidelines: Typically taken once daily Swallow the tablet whole with water Can be taken with or without food, but maintain consistency Monitoring Requirements: Regular blood tests to check kidney and liver function Monitoring drug levels ensures effectiveness and safety Missed Dose: Take the missed dose as soon as possible If it is near the next scheduled dose, skip the missed dose Do not double the dose Side Effects of EVERENOLIMUS 0.5 EVERENOLIMUS 0.5 may cause side effects, which can range from mild to serious. Common Side Effects: Fatigue and weakness Nausea or vomiting Mouth ulcers Diarrhea Less Common Side Effects: Edema (swelling in hands or feet) Increased blood sugar and cholesterol levels Skin rash Serious Side Effects: Increased risk of infections due to suppressed immunity Lung inflammation (non-infectious pneumonitis) Impaired kidney or liver function Delayed wound healing When to Seek Medical Attention: Persistent fever or signs of infection Shortness of breath or chest pain Severe weakness, dizziness, or swelling Unusual bleeding or bruising Precautions and Warning 1. Infection Risk Suppressed immunity increases susceptibility to infections Avoid exposure to people with contagious diseases 2. Liver and Kidney Function Regular tests are necessary to monitor organ health 3. Vaccinations Avoid live vaccines during treatment Consult your doctor before any vaccination 4. Drug Interactions Inform your doctor about all medications, including antibiotics, antifungals, and supplements 5. Pregnancy and Contraception Not recommended during pregnancy Effective contraception is advised during and after treatment 6. Surgery and Wound Healing Inform your doctor before undergoing surgery Wound healing may be delayed due to Everolimus effects 7. Sun Protection Increased sensitivity to sunlight Use sunscreen and protective clothing Conclusion EVERENOLIMUS 0.5 (Everolimus Tablets 0.5 mg) is a highly effective oral medication that offers dual benefits for cancer patients and organ transplant recipients. Its targeted mechanism ensures precise therapeutic action while minimizing unnecessary side effects. By preventing organ rejection, controlling tumor growth, and improving long-term outcomes, EVERENOLIMUS 0.5 has become a trusted choice in modern clinical practice. Patients in India seeking reliable, medically supervised care for complex conditions can benefit greatly from this advanced therapy. Strict adherence to dosage, regular monitoring, and medical supervision are essential for safe and effective use. Combined with lifestyle and dietary guidance, EVERENOLIMUS 0.5 supports improved quality of life and enhanced clinical outcomes.